Tag: shrooms
-
Revive (RVV.C) advances drug delivery tech for psychedelics
Revive has a partnership agreement with the Reed Research Group out of the University of Wisconsin-Madison to evaluate novel formulations of psilocybin.
-
Everything is up: Eat, drink, be merry… for tomorrow we die
When the history books are written on this passage of our lives, under pandemic lockdown and with once-in-three-generations levels of unemployment, they’ll note that in order to save us from economic collapse, the government printed trillions of dollars and just fired it all into the markets out of a bazooka, only to establish a decades-long…
-
Revive Therapeutics’ (RVV.C) product pipeline is flowing freakishly fast
Revive Therapeutics is exploring the use of the drug Bucillamine as a potential novel treatment for infectious diseases including influenza and the coronavirus disease (Covid-19)
-
Revive Therapeutics (RVV.C): Kicked around, called a fraud, gets FDA approval of Phase 3 COVID-19 trials
“Let them say what they want, we know what we’re doing, and we’re doing the work,” Michael Frank told me a month ago, as he put out news claiming his little pharma company, which had built a reputation for chasing aggressively into new pharmaceutical fields, had found some IP that might be useful in the…
-
Revive Therapeutics (RVV.C) finds pharma asset under the couch that may treat COVID-19
When new sectors emerge, as cannabis did in 2013 and psychedelics are doing right now, microcap companies that have struggled in other sectors will often pivot into new business. Miners become weed companies, then biotech companies, then shroom companies, as boards and management pursue new opportunities that might one day prove better than the last.
-
![Equity.Guru podcast: pt. 2 Yield Growth (BOSS.C) CEO Penny White talks about Urban Juve, topicals, mushrooms and more….]()
Equity.Guru podcast: pt. 2 Yield Growth (BOSS.C) CEO Penny White talks about Urban Juve, topicals, mushrooms and more….
In this, part 2 of a two-part interview, Penny White, CEO of Yield Growth, spoke with Equity.Guru’s Guy Bennett about the target market for Urban Juve, branding, packaging, South America, regulation, topicals, Wright & Well, mushrooms and the potential end game.
